P

Pfizer

Consumers who purchased EpiPens between August 2011 and November 2020 may have been eligible for a settlement payment.

ClosedUnited States-wideClaim status: Closed on November 12, 2021Payout: VariesNo longer claimable

About this settlement

Allegations of anticompetitive practices and overcharging for EpiPens.

This settlement resolves claims against Pfizer, Meridian Medical Technologies, and King Pharmaceuticals regarding the marketing, sales practices, and antitrust issues related to EpiPens. Consumers who purchased EpiPens for personal use between August 2011 and November 2020 may have been eligible for a settlement payment.

Who qualifies

  • Any person or entity in the United States who paid for or was reimbursed for some or all of the purchase price of branded or authorized generic EpiPens.
  • Purchases made for consumption, not resale, between Aug. 24, 2011, and Nov. 1, 2020.
  • Individuals who did not exclude themselves from the Class.

Varies

Claim status: Closed on November 12, 2021

See active Settlements

Related settlements

Keurig logo

Keurig

No proof required

Up to $50

13 days left

πŸ”₯ 505 started this claim

Silk and Great Value logo

Silk and Great Value

Proof required

Up to $300,000

113 days left

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

763 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon

Ticketmaster logo

Ticketmaster

No proof required

Compensation pending

Claims opening soon